Kallia-Raftopoulos S, Kalpaxis D L, Coutsogeorgopoulos C
Laboratory of Biochemistry, School of Medicine, University of Patras, Greece.
Mol Pharmacol. 1994 Nov;46(5):1009-14.
We have investigated the inhibition of peptide bond formation by the antibiotic lincomycin, at 150 mM NH4Cl. We have used an in vitro system in which a ribosomal ternary complex, the acetyl[3H] phenylalanine-tRNA-70 S ribosome-poly(U) complex (complex C), reacts with puromycin, forming peptide bonds. Complex C can be considered an analog of the elongating ribosomal complex and puromycin an analog of aminoacyl-tRNA. In a previous study we reported on the kinetics of inhibition by lincomycin at 100 mM NH4Cl. In the present investigation, we find that an increase of the ammonium ion concentration to 150 mM causes profound changes in the kinetic behavior of the system, which can be summarized as follows. First, the association rate for complex C and lincomycin is increased. At a lincomycin concentration of 10 microM the apparent equilibration rate constant is 4.3 min-1 at 100 mM NH4Cl, whereas it becomes 6.7 min-1 at 150 mM. Second, at 150 mM NH4Cl, with increasing concentrations of lincomycin, there is a transition from competitive to mixed-noncompetitive inhibition. The prevailing notion is that lincomycin acts at the ribosomal A-site, a mechanism that agrees only with competitive kinetics (mutually exclusive binding between puromycin and lincomycin). At the molecular level, the change in the kinetics of inhibition that we observe may mean that the mutually exclusive binding between aminoacyl-tRNA and lincomycin is converted to simultaneous binding, as a result of conformational changes occurring in the elongating ribosomal complex.
我们研究了抗生素林可霉素在150 mM氯化铵条件下对肽键形成的抑制作用。我们使用了一种体外系统,其中核糖体三元复合物,即乙酰基[³H]苯丙氨酸 - tRNA - 70S核糖体 - 聚(U)复合物(复合物C),与嘌呤霉素反应形成肽键。复合物C可被视为延伸核糖体复合物的类似物,嘌呤霉素可被视为氨酰 - tRNA的类似物。在先前的一项研究中,我们报道了林可霉素在100 mM氯化铵条件下的抑制动力学。在本研究中,我们发现铵离子浓度增加到150 mM会导致系统动力学行为发生深刻变化,可总结如下。首先,复合物C与林可霉素的结合速率增加。在林可霉素浓度为10 microM时,在100 mM氯化铵条件下表观平衡速率常数为4.3 min⁻¹,而在150 mM时变为6.7 min⁻¹。其次,在150 mM氯化铵条件下,随着林可霉素浓度的增加,抑制作用从竞争性转变为混合 - 非竞争性抑制。普遍的观点是林可霉素作用于核糖体A位点,这种机制仅与竞争性动力学相符(嘌呤霉素和林可霉素之间相互排斥结合)。在分子水平上,我们观察到的抑制动力学变化可能意味着,由于延伸核糖体复合物中发生的构象变化,氨酰 - tRNA与林可霉素之间的相互排斥结合转变为同时结合。